Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Asahi Kasei Corp    3407   JP3111200006

News SummaryMost relevantAll newsSector newsTweets 

Asahi Kasei Corp. : Construction of new acetonitrile plant in Korea

share with twitter share with LinkedIn share with facebook
share via e-mail
03/06/2012 | 04:35am CET

Asahi Kasei Chemicals Corp.

Asahi Kasei Chemicals has finalized a decision to construct a new acetonitrile plant in Korea. The plant will have a production capacity of 11,000 tons per year, and start-up is scheduled for January 2014. Having a second production base for acetonitrile, in addition to its Japanese base, will enable Asahi Kasei Chemicals to assure a reliable supply of acetonitrile as demand continues to grow rapidly worldwide.

Acetonitrile is produced by refining the crude acetonitrile obtained as a byproduct of acrylonitrile (AN). It is mainly used as a solvent in the manufacture of pharmaceuticals, with other notable uses including as analytical reagent and in the field of agrichemicals. With an acetonitrile plant in Kawasaki, Kanagawa, Japan, having a production capacity of 14,000 tons per year, Asahi Kasei Chemicals is a major supplier to markets in Asia and Europe as well as Japan. Strong growth in demand for acetonitrile is forecasted, particularly for use in the field of pharmaceutical manufacture. Asahi Kasei Chemicals had therefore been examining how best to increase production capacity and ensure reliable supply as markets continue to grow.

A decision was made to construct a new acetonitrile plant at Tong Suh Petrochemical Corp., Ltd., an Asahi Kasei Group company in Korea, which is currently constructing a new AN plant in Ulsan with startup scheduled for January 2013. The acetonitrile plant in Korea will utilize crude acetonitrile byproduct from the AN plants in Korea.

Having two production bases for acetonitrile, in Japan and Korea, will enable Asahi Kasei Chemicals to provide reliable supply to meet growing demand in the pharmaceutical industry especially in India and China.
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ASAHI KASEI CORP
01/13 ASAHI KASEI : Home Order Trends – December 2016
01/12 ASAHI KASEI : Announcement of marketing of Bredinin™ OD25 and Bredinin&tra..
01/06 ASAHI KASEI : "Hall Electromotive Force Signal Detection Circuit and Current Sen..
2016 ASAHI KASEI : Aryballe Technologies Secures USD3.5 Million in First Round of Fun..
2016 ASAHI KASEI : Patent Issued for Hall Electromotive Force Signal Detection Circui..
2016 ASAHI KASEI : Studies from Asahi Kasei Pharma Corp. Have Provided New Data on Li..
2016 ASAHI KASEI : Aryballe Technologies, a Start-up Backed by Innovacom Completes It..
2016 ASAHI KASEI : "Output-Current Detection Chip for Diode Sensors, and Diode Sensor..
2016 ASAHI KASEI : Zoll Medical Assigned Patent
2016 ASAHI KASEI : Announcement of listing on the NHI drug price standard and marketi..
More news
Sector news : Commodity Chemicals - NEC
01/18DJLYONDELLBASELL INDUSTRIES : Files 8K - Changes Executive Management
01/18 European shares retreat as Pearson plummets
01/17 Oil majors, car makers to push hydrogen technology to help cut emissions
01/13DJLINDE : German Regulator Examines Possible Insider Trading at Linde
01/11DJBraskem to Sell QuantiQ for BRL500 Million to GTM Holdings
More sector news : Commodity Chemicals - NEC
News from SeekingAlpha
06:52a Evotec collaborates with Japan's Asahi Kasei Pharma on drug discovery
2016 JAPANESE EQUITIES : False Dawn Or Rising Star?
2016 GMO International Active EAFE Strategy Q3 2016 Commentary
2016 A YEAR OF SCANDAL : The Beginning Of The End Of Cronyism In Japan?
2016 Array Bio licenses TrkA inhibitors to Asahi Kasei Pharma in Asia for up to $7..
Financials ( JPY)
Sales 2017 1 854 542 M
EBIT 2017 -
Net income 2017 98 642 M
Debt 2017 253 060 M
Yield 2017 2,02%
P/E ratio 2017 14,30
P/E ratio 2018 13,56
EV / Sales 2017 0,91x
EV / Sales 2018 0,85x
Capitalization 1 429 967 M
More Financials
Duration : Period :
Asahi Kasei Corp Technical Analysis Chart | 3407 | JP3111200006 | 4-Traders
Full-screen chart
Technical analysis trends ASAHI KASEI CORP
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus HOLD
Number of Analysts 13
Average target price 998  JPY
Spread / Average Target -2,1%
Consensus details
EPS Revisions
More Estimates Revisions
Hideki Kobori President & Representative Director
Ichiro Itoh Chairman
Norio Ichino Independent Director
Masafumi Nakao Director
Yuji Kobayashi Representative Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASAHI KASEI CORP-0.39%12 476
AIR LIQUIDE-3.08%42 375
PRAXAIR, INC.-0.50%33 276
More Results